Regional Planning for Extracorporeal Membrane Oxygenation Allocation During COVID-19
Drawing from a collaborative framework developed by one United States metropolitan area with multiple adult and pediatric extracorporeal life support centers, this article aims to inform decision-making around ECMO use during a pandemic such as COVID-19.
Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak
During the ongoing health emergency, all new patients admitted to hospital units hosting immunocompromised; complex; critical; and, more generally, acutely ill patients probably should be isolated initially and screened for SARS-CoV-2 infection, and separate pathways should be provided until the virological test results are obtained.
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new recommendations in further releases of these guidelines.
Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
For now—and possibly the next 18 to 24 months, convalescent plasma, despite supply issues and questions about efficacy and who is most likely to benefit from treatment, remains the only off-the-shelf therapy for COVID-19.
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy
The cumulative incidence of out-of-hospital cardiac arrest in 2020 was strongly associated with the cumulative incidence of Covid-19, and the increase in the number of cases of out-of-hospital cardiac arrest over the number in 2019 followed the time course of the Covid-19 outbreak
The Essential Role of Patient Blood Management in a Pandemic: A Call for Action
This multinational and diverse group of authors issue this “Call to Action” underscoring “The Essential Role of Patient Blood Management in the Management of Pandemics” and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches.
Patient Blood Management During the COVID‐19 Pandemic ‐ a Narrative Review
This review considers the impact of the COVID‐19 pandemic on the blood supply and specifies important aspects of donor management.
COVID-19 FAQ’s in Pediatric Cardiac Surgery
The purpose of this review is to succinctly summarize frequently asked questions related to COVID-19 as it relates to children with congenital heart disease.
Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence)
We have collected a total of 26 patients with COVID-19 who required extracorporeal membranous oxygenation (ECMO).
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients
These initial data may provide useful information to help define the best strategies to care for these challenging patients, and may also provide a framework for much-needed future research about the use of ECMO to treat patients with COVID-19.
COVID-19: Crisis Management in Congenital Heart Surgery
The safety of our patients, healthcare providers, and our communities is our chief concern. This document is not meant to be a guideline but is designed to provide guidance for decision-making as we face unparalleled challenges related to congenital cardiac surgery care during this pandemic.
Cardiac Surgery in Canada During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons
With strong representation from across the country and the support of the Canadian Cardiovascular Society, the authors have attempted to provide guidance to their colleagues on the subjects of leadership roles that cardiac surgeons may assume during this pandemic: patient assessment and triage, risk reduction, and real-time sharing of expertise and experiences.